Edwards Lifesciences Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	765,858	909,821	781,824	899,785	1,658,132	1,131,402
Market Cap Growth	-6.91%	16.37%	-13.11%	-45.73%	46.56%	23.28%
Enterprise Value	711,765	833,119	763,173	879,267	1,635,365	1,119,359
Last Close Price	1397.53	1543.21	1286.75	1425.52	2511.00	1795.37
PE Ratio	30.52	10.46	32.98	30.31	53.81	69.05
PS Ratio	7.10	8.03	9.23	10.33	15.46	12.96
PB Ratio	4.09	4.34	6.88	7.94	13.86	12.43
P/TBV Ratio	5.72	6.20	9.06	10.59	18.62	18.52
P/FCF Ratio	51.92	150.61	71.94	47.38	57.51	87.84
P/OCF Ratio	41.06	80.51	51.63	37.87	46.70	53.93
EV/Sales Ratio	7.04	7.35	9.01	10.10	15.25	12.83
EV/EBITDA Ratio	22.79	24.44	27.66	26.81	46.34	39.52
EV/EBIT Ratio	25.57	27.00	30.35	29.24	50.28	42.74
EV/FCF Ratio	48.25	137.92	70.23	46.30	56.73	86.91
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Debt / EBITDA Ratio	0.39	0.42	0.41	0.40	0.39	0.48
Debt / FCF Ratio	0.87	2.42	1.07	0.71	0.49	1.07
Asset Turnover	0.45	0.49	0.57	0.53	0.67	0.64
Inventory Turnover	1.14	1.12	1.10	0.90	1.63	1.50
Quick Ratio	2.98	3.13	2.06	1.87	2.07	2.24
Current Ratio	4.00	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	13.49%	16.64%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	7.71%	8.26%	10.53%	11.47%	12.60%	11.99%
Return on Invested Capital (ROIC)	19.24%	21.26%	23.92%	25.98%	31.39%	32.95%
Return on Capital Employed (ROCE)	13.90%	12.80%	18.20%	21.20%	21.20%	20.70%
Earnings Yield	3.28%	9.56%	3.03%	3.30%	1.86%	1.45%
FCF Yield	1.93%	0.66%	1.39%	2.11%	1.74%	1.14%
Buyback Yield / Dilution	2.54%	1.66%	2.37%	1.11%	0.11%	0.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.